This statistic depicts the number of currently active novel disease-modifying clinical trials for Alzheimer's disease drugs globally as of February 2019, by phase. At that time there were
**
Log in or register to access precise data.
active clinical trials for novel disease-modifying Alzheimer's drugs in phase II.
Adjust the presentation of the statistic and data points.
Share the statistic on social media channels or embed the statistic in your
website using "Embed Code", where available.
Cite this statistic and select one of the following formats: APA, Chicago, Harvard, MLA & Bluebook.
Print the statistic including description and metadata.
Chart type
Total number of currently active global novel disease-modifying clinical trials for Alzheimer's disease drugs in early 2019, by phase*
Share this statistic
You have no right to use this feature.
Make sure to contact us if you are interested in scientific citation.
You can upgrade your account to enable this functionality for all statistics.
This feature is not available with your current account.Request access
* Twelve programs listed as “Ex-US” in the Biomedtracker database are included here by phase based on independent research of company websites. This “Ex-US” listing implies the companies have not yet intended to seek FDA approval. No NDA/BLA filings were active for Alzheimer’s Disease as of February 28, 2019. Only novel approaches with disease modifying potential in Alzheimer’s disease are shown.
Learn more about how Statista can support your business.
Biotechnology Innovation Organization. (May 14, 2019). Total number of currently active global novel disease-modifying clinical trials for Alzheimer's disease drugs in early 2019, by phase* [Graph]. In Statista. Retrieved August 14, 2025, from https://www.statista.com/statistics/1029540/active-alzheimers-disease-modifying-drug-global-clinical-trials-by-phase/
Biotechnology Innovation Organization. "Total number of currently active global novel disease-modifying clinical trials for Alzheimer's disease drugs in early 2019, by phase*." Chart. May 14, 2019. Statista. Accessed August 14, 2025. https://www.statista.com/statistics/1029540/active-alzheimers-disease-modifying-drug-global-clinical-trials-by-phase/
Biotechnology Innovation Organization. (2019). Total number of currently active global novel disease-modifying clinical trials for Alzheimer's disease drugs in early 2019, by phase*. Statista. Statista Inc.. Accessed: August 14, 2025. https://www.statista.com/statistics/1029540/active-alzheimers-disease-modifying-drug-global-clinical-trials-by-phase/
Biotechnology Innovation Organization. "Total Number of Currently Active Global Novel Disease-modifying Clinical Trials for Alzheimer's Disease Drugs in Early 2019, by Phase*." Statista, Statista Inc., 14 May 2019, https://www.statista.com/statistics/1029540/active-alzheimers-disease-modifying-drug-global-clinical-trials-by-phase/
Biotechnology Innovation Organization, Total number of currently active global novel disease-modifying clinical trials for Alzheimer's disease drugs in early 2019, by phase* Statista, https://www.statista.com/statistics/1029540/active-alzheimers-disease-modifying-drug-global-clinical-trials-by-phase/ (last visited August 14, 2025)
Total number of currently active global novel disease-modifying clinical trials for Alzheimer's disease drugs in early 2019, by phase* [Graph], Biotechnology Innovation Organization, May 14, 2019. [Online]. Available: https://www.statista.com/statistics/1029540/active-alzheimers-disease-modifying-drug-global-clinical-trials-by-phase/
Advertisement
Profit from additional features with an Employee Account
Please create an employee account to be able to mark statistics as favorites.
Then you can access your favorite statistics via the star in the header.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
